Management of pain in advanced disease

Harris, Dylan G. 2014. Management of pain in advanced disease. British Medical Bulletin 110 (1) , pp. 117-128. 10.1093/bmb/ldu010

Full text not available from this repository.

Abstract

Background Pain is common in advanced malignancy but also prevalent in other non-malignant life-limiting diseases such as advanced heart disease; end stage renal failure and multiple sclerosis. Patients with renal or liver impairment need specific consideration, as most analgesics rely on either or both for their metabolism and excretion. Sources of data Recent evidence-based guidelines and the systematic reviews that have informed their recommendations. Areas of agreement The principles of the WHO (World Health Organisation) analgesic ladder are commonly endorsed as a structured approach to the management of pain. For neuropathic pain, the efficacy of different agents is similar and choice of drug more guided by side effects, drug interactions and cost. Areas of controversy Evidence supporting the WHO analgesic ladder is disputed and alternatives suggested, but no overwhelming evidence for an alternative approach exists to date. Growing points Alternative approaches to the WHO analgesic ladder, new analgesic agents, e.g. rapid onset oral/intranasal fentanyl.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Oxford University Press (OUP)
ISSN:	0007-1420
Date of Acceptance:	8 April 2014
Last Modified:	05 Jun 2019 13:05
URI:	https://orca.cardiff.ac.uk/id/eprint/116481

Citation Data

Cited 17 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item